Back
Bicara Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
BCAX
Bicara Therapeutics, Inc.
Last Price:
$16.79
Seasonality Move:
-32.17%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.
Bicara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.77 | Sell |
| 20-day SMA: | 18.17 | Sell |
| 50-day SMA: | 16.99 | Sell |
| 200-day SMA: | 13.32 | Buy |
| 8-day EMA: | 17.67 | Sell |
| 20-day EMA: | 17.74 | Sell |
| 50-day EMA: | 16.87 | Sell |
| 200-day EMA: | 14.01 | Buy |
Bicara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 43.72 | Sell |
| Chaikin Money Flow: | -190861 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.07 - 18.93) | Sell |
| Bollinger Bands (100): | (11.86 - 17.9) | Buy |
Bicara Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bicara Therapeutics, Inc. Stock
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 16.80 while BCAX 8-day simple moving average is 17.77, which is a Sell signal.
-
The stock price of BCAX is 16.80 while Bicara Therapeutics, Inc. 20-day SMA is 18.17, which makes it a Sell.
-
Bicara Therapeutics, Inc. 50-day simple moving average is 16.99 while BCAX share price is 16.80, making it a Sell technically.
-
BCAX stock price is 16.80 and Bicara Therapeutics, Inc. 200-day simple moving average is 13.32, creating a Buy signal.
BCAX Technical Analysis vs Fundamental Analysis
Sell
31
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Is Bicara Therapeutics, Inc. a Buy or a Sell?
-
Bicara Therapeutics, Inc. stock is rated a SellThe current Bicara Therapeutics, Inc. [BCAX] share price is $16.80. The Score for BCAX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Bicara Therapeutics, Inc. Stock Info
Market Cap:
920.3M
Price in USD:
16.80
Share Volume:
275.7K
Bicara Therapeutics, Inc. 52-Week Range
52-Week High:
19.71
52-Week Low:
7.80
Sell
31
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Bicara Therapeutics, Inc. Share Price Forecast
-
What is the Bicara Therapeutics, Inc. stock price today?The Bicara Therapeutics, Inc. stock price is 16.80 USD today.
-
Will BCAX stock go up or go down?Bicara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Bicara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bicara Therapeutics, Inc. is overvalued.
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 16.80 while BCAX 8-day exponential moving average is 17.67, which is a Sell signal.
-
The stock price of BCAX is 16.80 while Bicara Therapeutics, Inc. 20-day EMA is 17.74, which makes it a Sell.
-
Bicara Therapeutics, Inc. 50-day exponential moving average is 16.87 while BCAX share price is 16.80, making it a Sell technically.
-
BCAX stock price is 16.80 and Bicara Therapeutics, Inc. 200-day simple moving average is 14.01, creating a Buy signal.
Fundamental Analysis of Bicara Therapeutics, Inc.
Is Bicara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Bicara Therapeutics, Inc.
Should I short Bicara Therapeutics, Inc. stock?
-
BCAX Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Bicara Therapeutics, Inc. is a Buy
-
Bicara Therapeutics, Inc. Relative Strength Index (RSI) is 43.72, which suggest Bicara Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Bicara Therapeutics, Inc. is (17.07 - 18.93), which suggest Bicara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Bicara Therapeutics, Inc. is (11.86 - 17.9), which suggest Bicara Therapeutics, Inc. is a Buy
* Bicara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.